Matinas BioPharma Holdings, Inc. - FORM S-1/A - EX-23.1 - EXHIBIT 23.1 - February 7, 2014

Attached files

file filename
EX-4.2 - EXHIBIT 4.2 - Matinas BioPharma Holdings, Inc.v367181_ex4-2.htm
EX-2.1 - EXHIBIT 2.1 - Matinas BioPharma Holdings, Inc.v367181_ex2-1.htm
EX-3.1 - EXHIBIT 3.1 - Matinas BioPharma Holdings, Inc.v367181_ex3-1.htm
EX-3.2 - EXHIBIT 3.2 - Matinas BioPharma Holdings, Inc.v367181_ex3-2.htm
EX-4.1 - EXHIBIT 4.1 - Matinas BioPharma Holdings, Inc.v367181_ex4-1.htm
EX-4.3 - EXHIBIT 4.3 - Matinas BioPharma Holdings, Inc.v367181_ex4-3.htm
EX-5.1 - EXHIBIT 5.1 - Matinas BioPharma Holdings, Inc.v367181_ex5-1.htm
S-1/A - AMENDMENT TO FORM S-1 - Matinas BioPharma Holdings, Inc.v367181_s1a.htm
EX-10.9 - EXHIBIT 10.9 - Matinas BioPharma Holdings, Inc.v367181_ex10-9.htm
EX-21.1 - EXHIBIT 21.1 - Matinas BioPharma Holdings, Inc.v367181_ex21-1.htm
EX-10.1 - EXHIBIT 10.1 - Matinas BioPharma Holdings, Inc.v367181_ex10-1.htm
EX-10.15 - EXHIBIT 10.15 - Matinas BioPharma Holdings, Inc.v367181_ex10-15.htm
EX-10.16 - EXHIBIT 10.16 - Matinas BioPharma Holdings, Inc.v367181_ex10-16.htm
EX-10.17 - EXHIBIT 10.17 - Matinas BioPharma Holdings, Inc.v367181_ex10-17.htm
EX-10.2 - EXHIBIT 10.2 - Matinas BioPharma Holdings, Inc.v367181_ex10-2.htm
EX-10.3 - EXHIBIT 10.3 - Matinas BioPharma Holdings, Inc.v367181_ex10-3.htm
EX-10.4 - EXHIBIT 10.4 - Matinas BioPharma Holdings, Inc.v367181_ex10-4.htm
EX-10.5 - EXHIBIT 10.5 - Matinas BioPharma Holdings, Inc.v367181_ex10-5.htm
EX-10.6 - EXHIBIT 10.6 - Matinas BioPharma Holdings, Inc.v367181_ex10-6.htm
EX-10.8 - EXHIBIT 10.8 - Matinas BioPharma Holdings, Inc.v367181_ex10-8.htm
EX-10.7 - EXHIBIT 10.7 - Matinas BioPharma Holdings, Inc.v367181_ex10-7.htm
EX-10.10 - EXHIBIT 10.10 - Matinas BioPharma Holdings, Inc.v367181_ex10-10.htm
EX-10.11 - EXHIBIT 10.11 - Matinas BioPharma Holdings, Inc.v367181_ex10-11.htm
EX-10.12 - EXHIBIT 10.12 - Matinas BioPharma Holdings, Inc.v367181_ex10-12.htm
EX-10.13 - EXHIBIT 10.13 - Matinas BioPharma Holdings, Inc.v367181_ex10-13.htm
EX-10.14 - EXHIBIT 10.14 - Matinas BioPharma Holdings, Inc.v367181_ex10-14.htm

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the inclusion in this Registration Statement of Matinas BioPharma Holdings, Inc. on Form S-1 to be filed on or about January 21, 2014 of our report dated June 4, 2013 on our audits of the financial statements as of December 31, 2012 and 2011 and for the periods then ended December 31, 2012 and the cumulative period from August 11, 2011 (date of inception) to December 31, 2012.  Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company’s ability to continue as a going concern.  We also consent to the reference to our firm under the caption “Experts” in the Registration Statement on Form S-1.

 

 

/s/ EISNERAMPER LLP

 

 

 

Matinas BioPharma Holdings, Inc. Reports

Also read